miglyol-840 and Coronavirus-Infections

miglyol-840 has been researched along with Coronavirus-Infections* in 1 studies

Other Studies

1 other study(ies) available for miglyol-840 and Coronavirus-Infections

ArticleYear
Structure- and oil type-based efficacy of emulsion adjuvants.
    Vaccine, 2006, Jun-29, Volume: 24, Issue:26

    Oil-based emulsions are well-known immunopotentiators for inactivated, "killed" vaccines. We addressed the relationship between emulsion structure and levels of in vivo antibody formation to inactivated New Castle Disease virus (NDV) and Infectious Bronchitis virus (IBV) as antigens in 3-week-old chickens. The use of a polymeric emulsifier allowed for direct comparison of three types of emulsions, water-in-oil (W/O), oil-in-water (O/W) and W/O-in-water (W/O/W), while maintaining an identical content of components for each vehicle. They were prepared with either non-metabolizable, mineral oil or metabolizable, Miglyol 840. In addition, we assessed the inherent release capacity of each emulsion variant in vitro. Remarkably, we noted that W/O-type emulsions induced the best immune responses, while they released no antigen during 3 weeks. In general, mineral oil vaccines showed superior efficacy compared to Miglyol 840-based vaccines.

    Topics: Animals; Antibodies, Viral; Antigens, Viral; Chemistry, Pharmaceutical; Chickens; Coronavirus Infections; Diglycerides; Emulsions; Hexoses; Infectious bronchitis virus; Mineral Oil; Newcastle Disease; Polysorbates; Time Factors; Viral Vaccines

2006